PT781341E - Processo para a produção de proteínas recombinantes, plasmídeos e células modificadas - Google Patents

Processo para a produção de proteínas recombinantes, plasmídeos e células modificadas Download PDF

Info

Publication number
PT781341E
PT781341E PT95931242T PT95931242T PT781341E PT 781341 E PT781341 E PT 781341E PT 95931242 T PT95931242 T PT 95931242T PT 95931242 T PT95931242 T PT 95931242T PT 781341 E PT781341 E PT 781341E
Authority
PT
Portugal
Prior art keywords
plasmids
pct
production
recombinant proteins
modified cells
Prior art date
Application number
PT95931242T
Other languages
English (en)
Inventor
Joel Crouzet
Beatrice Cameron
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PT781341E publication Critical patent/PT781341E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PT95931242T 1994-09-16 1995-09-14 Processo para a produção de proteínas recombinantes, plasmídeos e células modificadas PT781341E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9411049A FR2724665B1 (fr) 1994-09-16 1994-09-16 Procede de production de proteines recombinantes, plasmides et cellules modifiees

Publications (1)

Publication Number Publication Date
PT781341E true PT781341E (pt) 2008-11-20

Family

ID=9466987

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95931242T PT781341E (pt) 1994-09-16 1995-09-14 Processo para a produção de proteínas recombinantes, plasmídeos e células modificadas

Country Status (19)

Country Link
US (1) US6143518A (pt)
EP (1) EP0781341B1 (pt)
JP (1) JP3696247B2 (pt)
KR (1) KR100391752B1 (pt)
AT (1) ATE405656T1 (pt)
AU (1) AU708080B2 (pt)
CA (1) CA2197804C (pt)
DE (1) DE69535815D1 (pt)
DK (1) DK0781341T3 (pt)
ES (1) ES2313721T3 (pt)
FI (1) FI120238B (pt)
FR (1) FR2724665B1 (pt)
IL (1) IL115308A (pt)
MX (1) MX9701614A (pt)
NO (1) NO320374B1 (pt)
PT (1) PT781341E (pt)
TW (1) TW517086B (pt)
WO (1) WO1996008572A1 (pt)
ZA (1) ZA957750B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618001D0 (en) 1996-08-29 1996-10-09 Nyfotek As Novel expression vectors
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
EP0998945A1 (en) * 1998-09-30 2000-05-10 Transgene S.A. Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
EP1022337B1 (en) * 1999-01-20 2006-07-26 Bayer HealthCare AG Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins
EP1022339B1 (en) 1999-01-20 2006-02-01 Bayer HealthCare AG Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins
JP2003512050A (ja) * 1999-10-19 2003-04-02 バラット バイオテック インターナショナル リミテッド 組換え成熟型リソフスタフィンの発現
CN101297036B (zh) * 2005-10-27 2013-03-13 株式会社钟化 新质粒载体和稳定保持质粒的转化体
US9051589B2 (en) * 2005-10-27 2015-06-09 Kaneka Corporation Plasmid vector and transformant stably retaining plasmid
CA2724277A1 (en) 2008-05-13 2009-11-19 Clarassance, Inc. Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis
RU2554745C2 (ru) 2009-10-15 2015-06-27 Кларассанс, Инк. Рекомбинантный человеческий белок сс10 для лечения гриппа
US9168285B2 (en) 2009-10-15 2015-10-27 Therabron Therapeutics, Inc. Recombinant human CC10 protein for treatment of influenza and ebola
BR102014014502B1 (pt) * 2014-06-13 2020-09-15 Ouro Fino Saúde Animal Ltda Vetor de expressão

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK410783D0 (da) * 1982-09-16 1983-09-09 Benzon A Salfred Fremgangsmade til stabilisering af plasmider
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
NZ220917A (en) * 1986-07-11 1991-05-28 Merck & Co Inc Human and bovine acidic fibroblast growth factor vectors, hosts and compositions
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
FR2642086B1 (fr) * 1989-01-26 1992-09-04 Sanofi Sa Gene recombinant codant pour un facteur basique de croissance des fibroblastes et ledit facteur
EP0406738A3 (en) * 1989-07-03 1991-08-14 Takeda Chemical Industries, Ltd. Production of acidic fgf protein
FR2661188B1 (fr) * 1990-04-24 1994-07-22 Rhone Poulenc Sante Nouveaux vecteurs de clonage et/ou d'expression, procede de preparation et leur utilisation.

Also Published As

Publication number Publication date
JPH10505746A (ja) 1998-06-09
IL115308A (en) 2009-07-20
FI971100A0 (fi) 1997-03-14
AU3475495A (en) 1996-03-29
AU708080B2 (en) 1999-07-29
FI120238B (fi) 2009-08-14
TW517086B (en) 2003-01-11
IL115308A0 (en) 1995-12-31
WO1996008572A1 (fr) 1996-03-21
NO971139D0 (no) 1997-03-12
KR100391752B1 (ko) 2003-10-22
ATE405656T1 (de) 2008-09-15
FI971100L (fi) 1997-03-14
NO320374B1 (no) 2005-11-28
CA2197804A1 (fr) 1996-03-21
FR2724665A1 (fr) 1996-03-22
FR2724665B1 (fr) 1996-12-20
DK0781341T3 (da) 2009-01-05
ZA957750B (en) 1996-04-24
EP0781341B1 (fr) 2008-08-20
EP0781341A1 (fr) 1997-07-02
MX9701614A (es) 1997-06-28
JP3696247B2 (ja) 2005-09-14
DE69535815D1 (de) 2008-10-02
ES2313721T3 (es) 2009-03-01
US6143518A (en) 2000-11-07
CA2197804C (fr) 2010-11-16
NO971139L (no) 1997-03-12

Similar Documents

Publication Publication Date Title
ATE343635T1 (de) Bmp-11 zusammenstellungen
NO950534L (no) Modufiserte soppceller og fremgangsmåter for fremstilling av rekombinante produkter
DK0575443T3 (da) Ærteproteinhydrolysat, fremgangsmåde til dets fremstilling og anvendelse deraf
DE50013610D1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
ZA957750B (en) Process for producing recombinant proteins plasmids and modified cells
HUT68021A (en) Improved activating process of recombinant proteins
DE60133271D1 (de) Behandlung von knorpelerkrankungen
BR9811592A (pt) Oxidase de citocinina
PT94680A (pt) Processo para a obtencao de uma proteina tendo actividade de urato oxidase gene recombinante que a codifica vector de expressao portador deste gene microorganismos procariotas e celulas eucariotas transformados por este vector de expressao
DK0562508T3 (da) Nyt knogle-relateret protein OSF-2, fremgangsmåde til dets fremstilling samt farmaceutisk præparat med indhold deraf
DE69821793D1 (de) Neuronale verwendungen des bmp-11
EP0546087A4 (pt)
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
DE59712554D1 (de) Rekombinante expression von s-layer-proteinen
PT704527E (pt) Sequencias de adn que codificam precursores de insulina biossinteticos e processo para a preparacao de insulina
ATE233321T1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
ATE214708T1 (de) Kationische mittel zur transfektion von nukleinsäuren
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
DE59410428D1 (de) Cholesterinoxidase aus brevibacterium sterolicum
DE69929683D1 (de) Antisense modulierung von lfa-3
PT1001929E (pt) Processo para o fabrico de acidos 3-ciano-2,4-di-halogeno-5-fluorobenzoicos
PT89916A (pt) Processo para a producao de proteinas modificadas
TR200002611T2 (tr) Beta-lipotropin ve kullanımları
BR9915537A (pt) Gene prv-1 e sua utilização
ITMI931034A1 (it) Processo per la preparazione di proteine inibenti i ribosomi